BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 31, 2001
View Archived Issues
Licensing opportunity from NIH: peptides that stabilize protein antigens
Read More
Licensing opportunity from NIH: neutralization site of HEV and use in vaccination
Read More
Licensing opportunity from NIH: N-CAM isoforms and psychiatric diseases
Read More
Baxter achieves significant R&D milestones during 2000
Read More
Oxagen and Incyte partner for gene-based osteoporosis research
Read More
Icos reports product pipeline update
Read More
Newly designed, highly active SOD mimetic protects against SAO shock
Read More
Peripherally administered Ono-8711 reduces postoperative mechanical hyperalgesia in rats
Read More
IY-81149 emerges from general pharmacological testing as potentially safe antiulcer drug
Read More
Kosan receives NCI grant to improve epothilone production
Read More
Caelyx receives approval in Canada for treatment of advanced ovarian cancer
Read More
Middle-aged women may reduce stroke risk by consuming more fish
Read More
Novel antibacterial substances designed to specifically inhibit bacterial enzymes
Read More
Antiinflammatory compounds in development at Abbott inhibit adhesion molecules
Read More
Lilly claims new modulators of metabotropic glutamate receptors and their uses
Read More
Recent patent covers Lilly's new muscarinic agents
Read More
New derivatives of echinocandin and their antifungal activity discussed in recent patents
Read More
Nortran's RSD-1235 shows efficacy in canine atrial arrhythmia model
Read More
Bradykinin fragment may offer a novel therapeutic strategy for septic shock
Read More
Phase II/III trial with OP-2000 for ulcerative colitis initiated
Read More
Potential Rx for neuropathic pain enters U.S. phase II trials
Read More
Organon licenses Cortex's Ampakines for depression
Read More
NIH funds will advance research on HIV vaccines at VaxGen
Read More
Nastech begins phase I trial of intranasal interferon alfa
Read More